BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 36758375)

  • 1. Spectrum of second primary malignancies and cause-specific mortality in pediatric and adult langerhans cell histiocytosis.
    Goyal G; Parikh R; Richman J; Abeykoon JP; Morlote D; Go RS; Bhatia S
    Leuk Res; 2023 Mar; 126():107032. PubMed ID: 36758375
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-term outcomes among adults with Langerhans cell histiocytosis.
    Goyal G; Acosta-Medina AA; Abeykoon JP; Dai C; Ravindran A; Vassallo R; Ryu JH; Shah MV; Bennani NN; Young JR; Bach CR; Ruan GJ; Zanwar S; Tobin WO; Koster MJ; Davidge-Pitts CJ; Gruber LM; Dasari S; Rech KL; Go RS
    Blood Adv; 2023 Nov; 7(21):6568-6578. PubMed ID: 37698994
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Risk of Second Primary Malignancies in Patients With Follicular Lymphoma: A United States Population-based Study.
    Giri S; Bhatt VR; Verma V; Pathak R; Bociek RG; Vose JM; Armitage JO
    Clin Lymphoma Myeloma Leuk; 2017 Sep; 17(9):569-574. PubMed ID: 28709798
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Second lymphomas and other malignant neoplasms in patients with mycosis fungoides and Sezary syndrome: evidence from population-based and clinical cohorts.
    Huang KP; Weinstock MA; Clarke CA; McMillan A; Hoppe RT; Kim YH
    Arch Dermatol; 2007 Jan; 143(1):45-50. PubMed ID: 17224541
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Malignancies diagnosed before and after anal squamous cell carcinomas: A SEER registry analysis.
    Jani KS; Lu SE; Murphy JD; Romesser PB; Jethwa KR; Li D; Chundury A; Wu AJ; Hathout L; Hallemeier CL; Jabbour SK
    Cancer Med; 2021 Jun; 10(11):3575-3583. PubMed ID: 33960690
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Langerhans cell histiocytosis in adults is associated with a high prevalence of hematologic and solid malignancies.
    Ma J; Laird JH; Chau KW; Chelius MR; Lok BH; Yahalom J
    Cancer Med; 2019 Jan; 8(1):58-66. PubMed ID: 30597769
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Second cancer incidence and cause-specific mortality among 3104 patients with hairy cell leukemia: a population-based study.
    Hisada M; Chen BE; Jaffe ES; Travis LB
    J Natl Cancer Inst; 2007 Feb; 99(3):215-22. PubMed ID: 17284716
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Trends in the risk of second primary malignancies among survivors of chronic lymphocytic leukemia.
    Kumar V; Ailawadhi S; Bojanini L; Mehta A; Biswas S; Sher T; Roy V; Vishnu P; Marin-Acevedo J; Alegria VR; Paulus A; Aulakh S; Iqbal M; Manochakian R; Tan W; Chanan-Khan A; Ailawadhi M
    Blood Cancer J; 2019 Sep; 9(10):75. PubMed ID: 31570695
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of Langerhans cell histiocytosis with malignant neoplasms.
    Egeler RM; Neglia JP; Puccetti DM; Brennan CA; Nesbit ME
    Cancer; 1993 Feb; 71(3):865-73. PubMed ID: 8431870
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Incidence Characteristics of Second Primary Malignancy after Diagnosis of Primary Colon and Rectal Cancer: A Population Based Study.
    Guan X; Jin Y; Chen Y; Jiang Z; Liu Z; Zhao Z; Yan P; Wang G; Wang X
    PLoS One; 2015; 10(11):e0143067. PubMed ID: 26571301
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risk of Subsequent Primary Kidney Cancer After Another Malignancy: A Population-based Study.
    Abdel-Rahman O
    Clin Genitourin Cancer; 2017 Oct; 15(5):e747-e754. PubMed ID: 28314541
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Risk of second primary malignancies following cutaneous melanoma diagnosis: a population-based study.
    Spanogle JP; Clarke CA; Aroner S; Swetter SM
    J Am Acad Dermatol; 2010 May; 62(5):757-67. PubMed ID: 20223559
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cutaneous Langerhans cell histiocytosis in elderly with chronic myelomonocytic leukemia.
    Iwasaki T; Takahashi I; Nagashima T; Igawa S; Komatsu S; Honma M; Ishida-Yamamoto A; Iizuka H
    J Dermatol; 2014 Mar; 41(3):262-5. PubMed ID: 24628074
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Trends in the Risks of Secondary Cancers in Patients With Hodgkin Lymphoma.
    Kumar V; Garg M; Chandra AB; Mayorga VS; Ahmed S; Ailawadhi S
    Clin Lymphoma Myeloma Leuk; 2018 Sep; 18(9):576-589.e1. PubMed ID: 29934060
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risk of developing glioblastoma following non-CNS primary cancer: a SEER analysis between 2000 and 2018.
    Dadey DYA; Medress ZA; Sharma M; Ugiliweneza B; Wang D; Rodrigues A; Parker J; Burton E; Williams B; Han SS; Boakye M; Skirboll S
    J Neurooncol; 2023 Sep; 164(3):655-662. PubMed ID: 37792220
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Second Primary Malignancies following a Diagnosis of Conjunctival Melanoma.
    Mahjoub H; Loya A; Ayaz T; Weng CY
    Curr Eye Res; 2022 Apr; 47(4):634-641. PubMed ID: 34898336
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Second Primary Malignant Neoplasms and Survival in Adolescent and Young Adult Cancer Survivors.
    Keegan THM; Bleyer A; Rosenberg AS; Li Q; Goldfarb M
    JAMA Oncol; 2017 Nov; 3(11):1554-1557. PubMed ID: 28426850
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Langerhans cell histiocytosis and associated malignancies: A retrospective analysis of 270 patients.
    Bagnasco F; Zimmermann SY; Egeler RM; Nanduri VR; Cammarata B; Donadieu J; Lehrnbecher T; Haupt R
    Eur J Cancer; 2022 Sep; 172():138-145. PubMed ID: 35772351
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risk of second primary malignancies of adolescent and young adult patients with germ cell cancer: A US population-based analysis.
    Jiang S; Jiang H; Sun L; Luo Z
    Curr Probl Cancer; 2021 Apr; 45(2):100641. PubMed ID: 32928566
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Langerhans cell histiocytosis first presenting in the skin in adults: frequent association with a second haematological malignancy.
    Edelbroek JR; Vermeer MH; Jansen PM; Stoof TJ; van der Linden MM; Horváth B; van Baarlen J; Willemze R
    Br J Dermatol; 2012 Dec; 167(6):1287-94. PubMed ID: 22835048
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.